Latest News and Press Releases
Want to stay updated on the latest news?
-
MOUNTAIN VIEW, Calif., May 1, 2012 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that it will report financial results for the first quarter ended March 31, 2012 after the NASDAQ...
-
MOUNTAIN VIEW, Calif., April 20, 2012 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) announced today that the Company's Board of Directors has appointed Ernest Mario, Ph.D. to serve on the Board of...
-
MOUNTAIN VIEW, Calif., April 9, 2012 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration (FDA) informed VIVUS (Nasdaq:VVUS) of an extended Prescription Drug User Fee Act (PDUFA) date for its...
-
MOUNTAIN VIEW, Calif., April 2, 2012 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that the Timothy Morris, chief financial officer, will present an overview of the company at the 11th...
-
MOUNTAIN VIEW, Calif., March 27, 2012 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS), a biopharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today...
-
MOUNTAIN VIEW, Calif., March 26, 2012 (GLOBE NEWSWIRE) -- VIVUS,Inc. (Nasdaq:VVUS) today announced that a Marketing Authorization Application (MAA) has been accepted by the European Medicines Agency...
-
MOUNTAIN VIEW, Calif., March 12, 2012 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that VIVUS management will present at two investor conferences during the month of March. The...
-
MOUNTAIN VIEW, Calif., Feb. 29, 2012 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) announced today the pricing of an underwritten public offering of 9,000,000 shares of its common stock at a price to...
-
MOUNTAIN VIEW, Calif., Feb. 28, 2012 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS), a biopharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today...
-
MOUNTAIN VIEW, Calif., Feb. 28, 2012 (GLOBE NEWSWIRE) -- VIVUS,Inc. (Nasdaq:VVUS), announced today that it is offering to sell, subject to market and other conditions, 8,500,000 shares of its common...